Two Glucose-Lowering Mechanisms of Canagliflozin Depending on Body Weight Changes in Drug-Naïve Subjects with Type 2 Diabetes

OBJECTIVES: The aim of this study was to investigate the relations between the changes in body weight and those of glycemic and non-glycemic parameters in drug-naïve subjects with type 2 diabetes mellitus (T2DM) treated with canagliflozin monotherapy. METHODS: Subjects received 50–100 mg/day canagli...

Descripción completa

Detalles Bibliográficos
Autores principales: Kutoh, Eiji, Wada, Asuka, Murayama, Teruma, Hayashi, Jyunka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2018
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6277318/
https://www.ncbi.nlm.nih.gov/pubmed/30324549
http://dx.doi.org/10.1007/s40268-018-0250-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6277318/
https://www.ncbi.nlm.nih.gov/pubmed/30324549
http://dx.doi.org/10.1007/s40268-018-0250-z

Ejemplares similares